Finny Kuruvilla, MD, PhD, and CIO of Eventide Funds, offers a unique perspective on COVID-19.
Finny Kuruvilla is chief investment officer for Eventide Funds, lead portfolio manager on the Eventide Gilead Fund, and portfolio manager on the Eventide Healthcare & Life Sciences Fund.
Dr. Kuruvilla has a unique background in healthcare, statistics, and investing. Concurrent with Eventide, from 2008 through 2016, he was a principal at Clarus Ventures, a leading healthcare and life sciences venture capital firm. Prior to joining Eventide, from 2006-2008, he was a research fellow at the Broad Institute of Harvard and MIT, and from 2005-2008, Dr. Kuruvilla was a clinical fellow at the Brigham and Women’s Hospital and Children’s Hospital Boston and a postdoctoral scientist at MIT.
He holds an MD from Harvard Medical School, a PhD in chemistry and chemical biology from Harvard University, a master’s degree in electrical engineering and computer science from MIT, and a bachelor’s degree from Caltech in Chemistry. Finny and his wife, Laura, have seven children and live in the Boston, Massachusetts area.